MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$1,248K
Net Income
-$23,363K
Net Profit Margin
-1872.04%
EPS
-$0.61
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-09-30
2025-06-30
2025-03-31
Collaboration revenue
1,248 8,659 8,513 4,127
Research and development
19,300 25,283 22,507 25,142
General and administrative
6,535 6,215 6,993 6,805
Total operating expenses
25,835 31,498 29,500 31,947
Loss from operations
-24,587 -22,839 -20,987 -27,820
Interest income
1,539 2,214 2,485 2,887
Change in fair value of long-term investments
NaN 0 1,292 NaN
Other expense, net
-1 -2 -70 -8
Total other income, net
1,538 2,212 1,123 2,879
Net loss before provision for income taxes
-23,049 -20,627 -19,864 -24,941
Provision for income taxes
10 -234 44 98
Net loss
-23,059 -20,393 -19,908 -25,039
Unrealized loss on available-for-sale marketable securities
-304 -1 -249 -88
Comprehensive loss
-23,363 -20,394 -20,157 -25,127
Basic EPS
-0.61 -0.55 -0.54 -0.68
Diluted EPS
-0.61 -0.55 -0.54 -0.68
Basic Average Shares
37,581,094 37,349,449 37,156,979 37,019,027
Diluted Average Shares
37,581,094 37,349,449 37,156,979 37,019,027
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Comprehensive loss-$23,363K (7.02%↑ Y/Y)Net loss-$23,059K (7.91%↑ Y/Y)Unrealized loss onavailable-for-sale marketable...-$304K (-245.45%↓ Y/Y)Interest income$1,539K (-46.69%↓ Y/Y)Net loss beforeprovision for income taxes-$23,049K (7.59%↑ Y/Y)Provision for income taxes$10K (-89.80%↓ Y/Y)Total other income,net$1,538K (-46.58%↓ Y/Y)Other expense, net-$1K (87.50%↑ Y/Y)Loss from operations-$24,587K (11.62%↑ Y/Y)Collaboration revenue$1,248K (-69.76%↓ Y/Y)Total operatingexpenses$25,835K (-19.13%↓ Y/Y)Research and development$19,300K (-23.24%↓ Y/Y)General andadministrative$6,535K (-3.97%↓ Y/Y)

Metagenomi Therapeutics, Inc. (MGX)

Metagenomi Therapeutics, Inc. (MGX)